Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/18/2025

Antidepressant Use in Pregnancy: Risks and Recommendations

Medication Safety Profile

  • Nortriptyline is a tricyclic antidepressant (TCA) that primarily increases norepinephrine levels in the brain, with less effect on serotonin compared to SSRIs, according to the American Academy of Child and Adolescent Psychiatry 1
  • Limited data on specific risks of nortriptyline during pregnancy compared to other antidepressants, as reported by the American Academy of Child and Adolescent Psychiatry 1

Risks Associated with Antidepressant Use

  • Possible increased risk of spontaneous abortion with nortriptyline use, though confounding by indication cannot be ruled out, as noted by the American College of Obstetricians and Gynecologists 2
  • Potential for poor neonatal adaptation syndrome when nortriptyline is used late in pregnancy, as reported by the American Academy of Family Physicians 3
  • Untreated depression during pregnancy is associated with adverse outcomes, including premature birth and decreased initiation of breastfeeding, according to the American Academy of Family Physicians 3

Clinical Considerations

  • Medications with more pregnancy safety data might be preferable when starting new treatment, as suggested by the American Academy of Family Physicians 3
  • Physiological changes in pregnancy may alter drug metabolism, potentially requiring dose adjustments, particularly in the third trimester, as reported by the American Journal of Obstetrics and Gynecology 2